230 related articles for article (PubMed ID: 25904122)
1. Epidemiological trends in uveal melanoma.
Andreoli MT; Mieler WF; Leiderman YI
Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
[TBL] [Abstract][Full Text] [Related]
2. Incidence of uveal melanoma in the United States: 1973-1997.
Singh AD; Topham A
Ophthalmology; 2003 May; 110(5):956-61. PubMed ID: 12750097
[TBL] [Abstract][Full Text] [Related]
3. Survival rates with uveal melanoma in the United States: 1973-1997.
Singh AD; Topham A
Ophthalmology; 2003 May; 110(5):962-5. PubMed ID: 12750098
[TBL] [Abstract][Full Text] [Related]
4. Uveal melanoma: Long-term survival.
Radivoyevitch T; Zabor EC; Singh AD
PLoS One; 2021; 16(5):e0250939. PubMed ID: 34003826
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry.
Andreoli MT; Chau FY; Shapiro MJ; Leiderman YI
Can J Ophthalmol; 2017 Dec; 52(6):592-598. PubMed ID: 29217028
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma: trends in incidence, treatment, and survival.
Singh AD; Turell ME; Topham AK
Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
Elavathil LJ; LeRiche J; Rootman J; Gallagher RP; Phillips D
Can J Ophthalmol; 1995 Dec; 30(7):360-5. PubMed ID: 8963937
[TBL] [Abstract][Full Text] [Related]
8. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
Stang A; Parkin DM; Ferlay J; Jöckel KH
Int J Cancer; 2005 Mar; 114(1):114-23. PubMed ID: 15523698
[TBL] [Abstract][Full Text] [Related]
9. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
10. Incidence of uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
[TBL] [Abstract][Full Text] [Related]
11. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
12. The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CH; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IH; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VM; Sagoo MS; Amiryan A; Saakyan S; Eide N; Krohn J; Midena E; Parrozzani R; Grange JD; Kilic E; Blasi MA; Saornil MA; Kivelä TT
Ophthalmology; 2016 Apr; 123(4):898-907. PubMed ID: 26854035
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
14. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
16. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
19. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma.
Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
Br J Ophthalmol; 2004 Jul; 88(7):892-5. PubMed ID: 15205232
[TBL] [Abstract][Full Text] [Related]
20. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
